CLINICAL TRIALS PROFILE FOR TRORILUZOLE
✉ Email this page to a colleague
Clinical Trials for troriluzole
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT02960893 ↗ | Trial in Adult Subjects With Spinocerebellar Ataxia | Active, not recruiting | Cognitive Research Corporation | Phase 2/Phase 3 | The primary purpose of this study is to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in subjects with spinocerebellar ataxia (SCA). |
NCT02960893 ↗ | Trial in Adult Subjects With Spinocerebellar Ataxia | Active, not recruiting | Cytel Inc. | Phase 2/Phase 3 | The primary purpose of this study is to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in subjects with spinocerebellar ataxia (SCA). |
NCT02960893 ↗ | Trial in Adult Subjects With Spinocerebellar Ataxia | Active, not recruiting | Biohaven Pharmaceutical Holding Company Ltd. | Phase 2/Phase 3 | The primary purpose of this study is to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in subjects with spinocerebellar ataxia (SCA). |
NCT02960893 ↗ | Trial in Adult Subjects With Spinocerebellar Ataxia | Active, not recruiting | Biohaven Pharmaceuticals, Inc. | Phase 2/Phase 3 | The primary purpose of this study is to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in subjects with spinocerebellar ataxia (SCA). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for troriluzole
Condition Name
Clinical Trial Locations for troriluzole
Trials by Country
Clinical Trial Progress for troriluzole
Clinical Trial Phase
Clinical Trial Sponsors for troriluzole
Sponsor Name